Heart Disease News and Research

Latest Heart Disease News and Research

State highlights: Heroin deaths rise in N.Y.; TennCare computer system delay; Colo. races to win $87M to integrate care;

A heroin crisis gripping communities across the country deepened in New York last year, with more people in the city dying in overdoses from the drug than in any year since 2003. In all, 420 people fatally overdosed on heroin in 2013 out of a total of 782 drug overdoses, rising to a level not seen in a decade in both absolute numbers and as a population-adjusted rate, according to preliminary year-end data from the city's health department (Goodman, 8/28).

29 Aug 2014

School nurses reach 98% of students in U.S. public schools to diagnose primary immunodeficiency

School nurses reach 98 percent of the 50,000,000 students in U.S. public schools, grades k-12, and are uniquely positioned to facilitate the early diagnosis of serious medical conditions such as primary immunodeficiency (PI).

28 Aug 2014

Amgen seeks FDA approval for evolocumab to treat patients with high cholesterol

Amgen today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration for evolocumab seeking approval for the treatment of high cholesterol.

28 Aug 2014

Childhood inflammation linked to adult psychosis

Elevated levels of the inflammatory marker interleukin -6 in childhood are associated with an increased risk of psychosis and depression in adulthood, research shows.

28 Aug 2014

Optimal personalised treatment improves bipolar life quality, functioning

Optimal personalised treatment improves quality of life and functioning of patients with bipolar disorder type I or II, suggests research published in the Journal of Affective Disorders.

28 Aug 2014

Aberrant reward processing likely to precede bipolar symptom onset

Healthy children who have a parent with bipolar disorder show altered brain activation during reward processing, research shows.

28 Aug 2014

Risk-based treatment approach should be considered for patients with hypertension

Blood pressure-lowering treatment should target patients at greatest cardiovascular risk and not just those with the highest baseline levels, suggest findings of a meta-analysis.

28 Aug 2014

Lifestyle intervention shows kidney benefits in diabetic patients

A lifestyle intervention focused on weight loss and increasing physical activity should be considered as additional treatment to prevent advanced kidney disease in overweight or obese people with Type 2 diabetes, say researchers.

28 Aug 2014

Merz Pharmaceuticals launches new CAIDE Dementia Risk App

The CAIDE Dementia Risk App from Merz Pharmaceuticals is available free of charge for people from 40 to 65 to calculate their individual risk for getting dementia within the next two decades. Using a traffic light color scheme, the App can also help physicians discuss preventive measures with patients at risk.

28 Aug 2014

Isis Pharmaceuticals begins ISIS-APOCIIIRx Phase 3 study in FCS patients

Isis Pharmaceuticals, Inc. announced the initiation of a Phase 3 study evaluating ISIS-APOCIIIRx in patients with familial chylomicronemia syndrome (FCS). FCS is a rare orphan disease, characterized by extremely high triglyceride levels, that affects an estimated 3,000 to 5,000 patients worldwide.

28 Aug 2014

Armetheon raises $7 million in first round of financing

Armetheon, Inc., a biopharmaceutical company focused on developing novel mid- to late-stage cardiovascular drug candidates, today announced that it has raised $7.0 million in its first round of financing.

28 Aug 2014

First Edition: August 28, 2014

Today's headlines include reports about the Congressional Budget Office's latest projections regarding Medicare and Medicaid spending.

28 Aug 2014

New UCLA study finds that oxidized lipids may also contribute to pulmonary hypertension

Oxidized lipids are known to play a key role in inflaming blood vessels and hardening arteries, which causes diseases like atherosclerosis. A new study at UCLA demonstrates that they may also contribute to pulmonary hypertension, a serious lung disease that narrows the small blood vessels in the lungs.

28 Aug 2014

Receiving prescription at discharge improves outcomes in stroke patients

Stroke patients are 70 per cent more likely to continue taking their stroke prevention medications one year later if they have a prescription in hand when discharged - according to researchers at St. Michael's Hospital and the Institute for Clinical Evaluative Sciences.

28 Aug 2014

Heart Disease News and Research

Latest Heart Disease News and Research

State highlights: Heroin deaths rise in N.Y.; TennCare computer system delay; Colo. races to win $87M to integrate care;

School nurses reach 98% of students in U.S. public schools to diagnose primary immunodeficiency

Amgen seeks FDA approval for evolocumab to treat patients with high cholesterol

Childhood inflammation linked to adult psychosis

Optimal personalised treatment improves bipolar life quality, functioning

Aberrant reward processing likely to precede bipolar symptom onset

Risk-based treatment approach should be considered for patients with hypertension

Lifestyle intervention shows kidney benefits in diabetic patients

Merz Pharmaceuticals launches new CAIDE Dementia Risk App

Isis Pharmaceuticals begins ISIS-APOCIIIRx Phase 3 study in FCS patients

Armetheon raises $7 million in first round of financing

First Edition: August 28, 2014

New UCLA study finds that oxidized lipids may also contribute to pulmonary hypertension

Receiving prescription at discharge improves outcomes in stroke patients

Amgen's ivabradine receives FDA priority review designation for treatment of chronic heart failure

Remote monitoring of implanted pacemakers and defibrillators: an interview with Dr. Suneet Mittal

Asterias receives clearance from FDA to initiate Phase 1/2a clinical trial of AST-OPC1

Continuous positive airway pressure treatment effective for older patients with OSA

Unregulated trash burning around the globe pumps more air pollution

Viewpoints: Check out those nursing home stars; Rove a 'bleeding heart liberal' on Medicare?

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Heart Disease News and Research

Latest Heart Disease News and Research

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Newsletters you may be interested in